Products

Austrius Trade

Trading can’t be guesswork.

austrius.trade Finance / Investing & Trading

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$15.83/mo
Lower than 53% of peersNiche median $19/mo
Creators
Paulo Wesley
No social account linked
Launched
23d ago
2026-10-27 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    See who's moving Brazil's futures market, live

    Oct 27 · 23d agoLaunch page

    At the time: <5K visits/mo

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2024-09-30

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Annual
$190/yr (billed annually)

Trial: None · 1 paid tier ($190) · Observed 2026-11-07 · Source page

Entry price $15.83/mo, Lower than 53% of peers; “Investing & Trading” median is $19/mo.View pricing benchmark

Pages & changes

Tracked since 2026-10-27

Key pages

Weekly snapshots
Home
austrius.trade/en Snapshot 2026-11-07

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does Austrius Trade cost?
Annual: $190/yr (billed annually). Observed 2026-11-07. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Austrius Trade get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Austrius Trade and what platforms does it support?
Austrius Trade is catalogued under Investing & Trading: Trading can’t be guesswork. Supported platforms: Web.

Related products in this category

Finance / Investing & Trading

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.